Investigación y desarrollo
EGFR and PTEN gene alterations predicts survival in patients with brain tumors
PCT/EP2010/069058
The invention relates to methods of predicting the clinical outcome of brain cancer patients based on the LOH levels of the PTEN gene and on the expression levels or the polysomy / amplification levels of EGFR gene in a sample from said patients.
Inventors
- DONOVAN, Michael J.
- COLOMER VALERO, Anna
- ERILL SAGALÉS, Nadina
- FERRER ABIZANDA, Isidre
- BOLUDA CASAS, Susana
More information
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2011070005